- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07668128
Tactile Feedback Pelvic Floor Training to Prevent Stress Urinary Incontinence in the 3rd Trimester of Pregnancy
Tactile Feedback on Pelvic Floor Muscle Training in the 3rd Trimester of Pregnancy to Prevent of Stress Urinary Incontinence and Its Influence on Biological and Psychological Symptoms
Pregnancy involves significant physiological changes, such as hormone fluctuations, weight gain, and fetal growth, which can affect multiple organ systems. These changes often lead to symptoms like stress urinary incontinence (SUI) and may worsen existing conditions. SUI affects about one-third of pregnant women and can decrease quality of life.
Pelvic floor muscle exercise (PFME) is a recommended treatment to manage urinary incontinence during pregnancy and postpartum. This study aims to compare the effectiveness of three interventions: routine health education, traditional PFME, and tactile feedback PFME, on reducing SUI symptoms, shortening the second stage of labor, and improving quality of life.
Participants will be enrolled in their third trimester and randomly assigned to one of the three groups, with each intervention lasting 8 weeks. Outcome measures include urinary symptoms (via bladder diary, UDI-6, and IIQ-7), quality of life (via KHQ and WHOQOL-BREF), and labor outcomes (duration of the second stage).
Study Overview
Status
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Banqiao Dist
-
New Taipei City, Banqiao Dist, Taiwan
- Far Eastern Memorial Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Pregnant women diagnosed with urinary incontinence by obstetricians or gynecologists during prenatal care.
- Women aged 20 years or older.
- Pregnant at 29 weeks of gestation.
- Singleton pregnancy with cephalic presentation.
- Anticipated vaginal delivery.
- Able to communicate and complete questionnaires without difficulty.
- Willing to participate and provide informed consent.
Exclusion Criteria:
- Diagnosed with high-risk pregnancy or at risk of preterm labor.
- Visual impairment or physical disability that limits participation.
- Currently taking medication for urinary incontinence during pregnancy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Basic Health Education Group
Participants in this group receive a one-time, written health education leaflet, without any physical or in-person instruction.
The leaflet includes information on the occurrence and causes of urinary incontinence during pregnancy, dietary recommendations, weight management, and illustrated instructions for Kegel exercises.
|
One-way, one-time health education leaflets are provided for written teaching, with only explanations but no physical teaching.
The content of the health education leaflets includes urinary incontinence during pregnancy, its causes, daily diet, weight control, and Kegel exercise execution methods and movements.
|
|
Active Comparator: Kegel Exercise Group
Participants in this group receive four in-person sessions of conventional pelvic floor muscle training (PFMT) over an 8-week period.
The training is delivered through interactive, hands-on teaching methods, incorporating posture positioning, guided breathing techniques, and imagery-based instructions (e.g., "closing the door," squeezing the buttocks) to enhance awareness and execution of Kegel contractions.
|
"Four in-person traditional pelvic floor muscle training sessions are scheduled over an eight-week period.
The training involves interactive, hands-on teaching that incorporates body positioning, guided breathing, and the 'closing and opening gate' theory.
This includes imagery techniques such as buttock squeezing and simulating the action of stopping urine flow to facilitate pelvic floor muscle contractions.
|
|
Experimental: Sensorimotor-Enhanced PFMT
This group receives sensorimotor-enhanced pelvic floor muscle training (PFMT) in four in-person sessions over an 8-week period.
The training incorporates interactive instruction with body positioning, guided deep breathing, and finger-based tactile feedback.
Participants are guided to sense the lift and contraction of their pelvic floor muscles through palpation techniques, aiming to enhance muscle awareness and neuromuscular coordination.
|
There are four physical tactile pelvic floor muscle training courses arranged in eight weeks.
The training process adopts two-way interactive practical teaching, using movement positioning and deep breathing to induce adjustment of the upper and lower strength of the pelvic floor, and using finger tactile feedback to feel the muscles lifting and contracting up and down during training.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Urinary Symptoms (Bladder Diary)
Time Frame: Baseline, 4 weeks, and 8 weeks post-intervention
|
Mean number of normal voiding episodes per day, urinary incontinence episodes per day, urinary urgency episodes per day, and mean daily fluid intake recorded using a 3-day bladder diary.
|
Baseline, 4 weeks, and 8 weeks post-intervention
|
|
Urinary Symptom Distress (UDI-6)
Time Frame: Baseline, 4 weeks, and 8 weeks post-intervention
|
Total score measured using the Urinary Distress Inventory-6 (UDI-6).
Scores range from 0 to 100, with higher scores indicating greater urinary symptom distress.
|
Baseline, 4 weeks, and 8 weeks post-intervention
|
|
Incontinence Impact on Daily Life (IIQ-7)
Time Frame: Baseline, 4 weeks, and 8 weeks post-intervention
|
Total score measured using the Incontinence Impact Questionnaire-7 (IIQ-7).
Scores range from 0 to 100, with higher scores indicating greater impact of urinary incontinence on daily activities.
|
Baseline, 4 weeks, and 8 weeks post-intervention
|
|
Urinary Incontinence-Related Quality of Life (KHQ)
Time Frame: Baseline, 4 weeks, and 8 weeks post-intervention
|
Domain scores measured using the King's Health Questionnaire (KHQ), including General Health Perception, Role Limitation, Physical Limitation, Social Limitation, Personal Relationships, Emotions, Sleep/Energy, and Severity Measures.
Scores range from 0 to 100, with higher scores indicating poorer quality of life.
|
Baseline, 4 weeks, and 8 weeks post-intervention
|
|
Global Quality of Life (WHOQOL-BREF Taiwan Version)
Time Frame: Baseline, 4 weeks, and 8 weeks post-intervention
|
Total score measured using the WHOQOL-BREF Taiwan Version.
Higher scores indicate better quality of life.
|
Baseline, 4 weeks, and 8 weeks post-intervention
|
|
International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form(ICIQ-UI-SF)
Time Frame: Baseline, 4 weeks, and 8 weeks post-intervention
|
Scores range from 0 to 21, with higher scores indicating greater urinary symptom severity.
|
Baseline, 4 weeks, and 8 weeks post-intervention
|
|
Brief Pain Inventory(BPI)
Time Frame: Baseline, 4 weeks, and 8 weeks post-intervention
|
Scores range from 0 to 10, with higher scores indicating greater pain severity or greater interference with daily activities.
|
Baseline, 4 weeks, and 8 weeks post-intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Duration of Second Stage of Labor
Time Frame: At delivery
|
Duration of the second stage of labor obtained from medical records.
|
At delivery
|
|
The Pittsburgh Sleep Quality Index (PSQI)
Time Frame: Baseline, 4 weeks, and 8 weeks post-intervention
|
Scores range from 0 to 21, with higher scores indicating poorer sleep quality.
|
Baseline, 4 weeks, and 8 weeks post-intervention
|
|
Pelvic Floor Muscle Exercise Self-Efficacy Scale
Time Frame: Baseline, 4 weeks, and 8 weeks post-intervention
|
Scores range from 17 to 85, with higher scores indicating greater self-efficacy for performing pelvic floor muscle exercises.
|
Baseline, 4 weeks, and 8 weeks post-intervention
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Urogenital Diseases
- Male Urogenital Diseases
- Urologic Diseases
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urination Disorders
- Lower Urinary Tract Symptoms
- Urological Manifestations
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Urinary Incontinence
- Urinary Incontinence, Stress
Other Study ID Numbers
- 111302-F
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.